Whalegun
Home

Jonathan Zalevsky, Chief R&D Officer: Nektar Therapeutics NKTR Sell · Filed 01/22

Trade details

Type
Insider sale
Amount
$137,935.89
Shares · price
3,867 sh · $35.67 a share
Held after
21,354 sh
Stock
Nektar Therapeutics NKTR
Person
Jonathan ZalevskyChief R&D Officer
Trade date
26/01/20
Filed
26/01/22
Days to filing
2 days

Sold 15.3% of holdings

Share of holding sold
15.3%

Nektar Therapeutics trades, last 26 weeks

What else happened in Nektar Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/21~02/19

Jonathan Zalevsky's recent trades

  • Jonathan Zalevsky

    Planned saleNektar Therapeutics

    $13.4K

    Filed 08/18

  • Jonathan Zalevsky

    Planned sale10b5-1 planNektar Therapeutics

    $371.5K

    Filed 06/30

  • Jonathan Zalevsky

    Sell10b5-1 planNektar Therapeutics

    $336.2K

    Filed 06/17

  • Jonathan Zalevsky

    Planned sale10b5-1 planNektar Therapeutics

    $328.8K

    Filed 06/15

  • Jonathan Zalevsky

    SellNektar Therapeutics

    $13K

    Filed 05/21

Jonathan Zalevsky, Chief Officer — sold $137.9K of Nektar Therapeutics NKTR · 15.3% of holdings · 10b5-1 plan | Whalegun